ROLE OF EPINEPHRINE IN PREVENTION OF PACEMAKER POCKET HEMATOMA
Abstract
To assess effectiveness and safety of administration of epinephrine during local anesthesia in the course of pacemaker implantation for prevention of the pacemaker pocket hematoma, 133 patients were examined and treated.
About the Authors
A. A. Nechepurenko
ФГБУ «Федеральный центр сердечно-сосудистой хирургии»
Russian Federation
Russian Federation
N. N. Ilov
ФГБУ «Федеральный центр сердечно-сосудистой хирургии»
Russian Federation
Russian Federation
A. M. Abdulkadyrov
ФГБУ «Федеральный центр сердечно-сосудистой хирургии»
Russian Federation
Russian Federation
D. R. Paskeev
ФГБУ «Федеральный центр сердечно-сосудистой хирургии»
Russian Federation
Russian Federation
E. V. Damrina
ФГБУ «Федеральный центр сердечно-сосудистой хирургии»
Russian Federation
Russian Federation
E. A. Kulikova
ФГБУ «Федеральный центр сердечно-сосудистой хирургии»
Russian Federation
Russian Federation
M. G. Terentyeva
ФГБУ «Федеральный центр сердечно-сосудистой хирургии»
Russian Federation
Russian Federation
M. I. Markina
ФГБУ «Федеральный центр сердечно-сосудистой хирургии»
Russian Federation
Russian Federation
D. R. Stompel
ФГБУ «Федеральный центр сердечно-сосудистой хирургии»
Russian Federation
Russian Federation
D. G. Tarasov
ФГБУ «Федеральный центр сердечно-сосудистой хирургии»
Russian Federation
Russian Federation
References
1. Ohlow, M.A. Pocket related complications in 163 patients receiving anticoagulation or dual antiplatelet therapy: D-Stat hemostat versus standard of care / M.A. Ohlow, B. Lauer, M. Schreiber // Int J Cardiol - 2012. - 159. - P. 177-180.
2. Cardiac device infections is associated with pocket hematoma and diabetes mellitus: The role of the cardiovascular nurse / F.V. Martin-Casanas [et al.] // International Journal of Cardiology. - 2014. - 171. - e5-e7.
3. Early complications of permanent pacemaker implantation: no difference between dual and single chamber systems / R.K. Aggarwal [et al.] // Br Heart J - 1995. - 73. - P. 571-575.
4. Двухлетний опыт эндокардиальной стимуляции сердца / В.В. Макеев [и др.] // Вестник аритмологии. - 1999. - №14. - С. 76.
5. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/ anticoagulation therapy / U.K. Wiegand [et al.] // Chest. - 2004. - 126. - P. 1177-1186.
6. Association between hospital procedure volume and early complications after pacemaker implantation: results from a large, unselected, contemporary cohort of the German nationwide obligatory external quality assurance programme / B.Nowak [et al.] // Europace. - 2015. - 17(5). - P. 787-793.
7. Anticoagulation and antiplatelet therapy in implantation of electrophysiological devices / Panagiotis Korantzopoulos [et al.] // Europace - 2011. - 13. - P. 1669-1680.
8. Birnie, D.H. Wells Pacemaker or Defibrillator surgery without interruption of anticoagulation / D. H. Birnie, J. S. Healey, G. A. Wells // The New England Journal of Medicine. - 2013 - 368. - P. 2084-2092.
9. Thrombocytopenia, dual antiplatelet therapy, and heparin bridging strategy increase pocket hematoma complications in patients undergoing cardiac rhythm device implantation / H.C. Chen [et al.] // - 2013. - №29(9). - P. 1110-1117.
10. Modern Pacemakers - Present and Future. Edited by Mithilesh Kumar Das, 2011. - Chapter 16. - P. 308-309.
11. Волков, Д.Е. Хирургические аспекты трансвенозной имплантации электрокардиостимуляторов: наш подход к снижению риска гнойно-воспалительных осложнений / Д.Е. Волков // Харьковская хирургическая школа.с- 2013. - 3(60). - С. 115-118.
12. Risk of Hematoma Complications After Device Implant in the Clopidogrel Era / I.B. Kutinsky [et al.] // Circ Arrhythm Electrophysiol. - 2010. -3. - P. 312-318.
13. Имплантация электрокардиостимулятора. Медицинская технология. Новосибирск, 2008. - 29 С.
14. Prevention of pocket related complications with fibrin sealant in patients undergoing pacemaker implantation who are receiving anticoagulant treatment / D. J. Milic [et al.] // Europace. - 2005. - 7. - P. 374-379.
15. Pocket Hematoma: A Call for Definition / D.E. Sensi [et al.] // Pacing Clin Electrophysiol. - 2015. - 38(8). - P. 909-913.
16. Niederhuber, J.E. Totally Implantable Venous Access Devices. Management in Mid- and Long-term Clinical Setting. Part IV / J. E. Niederhuber. - Milan: Springer, 2012. - P. 153-156.
17. Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients / J.B. Johansen [et al.] // Eur Heart J. - 2011. - 32(8). P. 991-998.
18. Hematoma complicating permanent pacemaker implantation: The role of periprocedural antiplatelet or anticoagulant therapy / K.S. Özcan [et al.] // Journal of Cardiology. - 2013. - 62. - P. 127-130.
19. Polyzos, K.A. Risk factors for cardiac implantable electronic device infection: a systematic review and metaanalysis / K.A. Polyzos, A.A. Konstantelias, M.E. Falagas // Europace. - 201. -17(5). - P. 767-777.
Review
For citations:
Nechepurenko A.A., Ilov N.N., Abdulkadyrov A.M., Paskeev D.R., Damrina E.V., Kulikova E.A., Terentyeva M.G., Markina M.I., Stompel D.R., Tarasov D.G. ROLE OF EPINEPHRINE IN PREVENTION OF PACEMAKER POCKET HEMATOMA. Journal of Arrhythmology. 2016;(84):28-34. (In Russ.)
Views:
155
Email this article 